Diversified Tracked since Q4 FY26 - Q4 FY26

Hester Biosciences Limited

Compare with...

HESTERBIO

Latest quarter Q4 FY26

Revenue ₹100 Cr

Management credibility Building

Promise tracking available after 2+ quarters of coverage.

View all executive profiles for Hester Biosciences Limited

Latest signal bullish medium

Hester Biosciences reported a strong Q4 FY26 with standalone revenue growing 22% YoY and PAT surging 174% YoY, driven...

Quarterly Earnings Timeline

Financial verification status, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q4 FY26 15 May 2026

Revenue ₹100 Cr

Hester Biosciences reported a strong Q4 FY26 with standalone revenue growing 22% YoY and PAT surging 174% YoY, driven by a 41% YoY jump in poultry healthcare revenue.

bullish medium

Scorecard starts after historical backfill Read full analysis →